Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Mar 18, 2016 $31.74 $33.06 $30.81 $31.58 776 700
Mar 17, 2016 $32.84 $32.86 $30.66 $31.50 504 900
Mar 16, 2016 $34.00 $34.44 $31.48 $32.87 396 900
Mar 15, 2016 $36.29 $36.84 $34.00 $34.18 586 200
Mar 14, 2016 $34.46 $37.49 $34.46 $37.03 680 400
Mar 11, 2016 $33.81 $34.61 $33.01 $34.47 369 600
Mar 10, 2016 $33.12 $35.59 $31.69 $33.01 437 500
Mar 09, 2016 $34.27 $35.42 $32.14 $32.84 457 200
Mar 08, 2016 $35.80 $36.42 $33.90 $34.25 621 100
Mar 07, 2016 $33.73 $36.41 $33.48 $36.09 503 800
Mar 04, 2016 $33.70 $34.98 $32.79 $34.01 538 500
Mar 03, 2016 $34.34 $34.75 $32.77 $33.65 478 500
Mar 02, 2016 $30.07 $35.00 $29.69 $34.30 770 400
Mar 01, 2016 $29.69 $30.54 $28.26 $30.17 563 600
Feb 29, 2016 $31.00 $32.34 $29.22 $29.40 405 300
Feb 26, 2016 $30.69 $31.52 $29.97 $30.92 295 400
Feb 25, 2016 $30.97 $32.60 $30.00 $30.58 533 000
Feb 24, 2016 $31.37 $31.39 $28.97 $30.75 666 100
Feb 23, 2016 $32.99 $33.39 $32.00 $32.11 391 900
Feb 22, 2016 $32.51 $33.81 $32.23 $33.14 457 400
Feb 19, 2016 $31.02 $32.08 $30.40 $31.87 441 200
Feb 18, 2016 $33.82 $34.19 $31.11 $31.31 364 700
Feb 17, 2016 $32.86 $34.25 $31.81 $33.82 547 700
Feb 16, 2016 $32.51 $33.43 $31.82 $32.69 561 500
Feb 12, 2016 $31.03 $32.67 $30.02 $32.05 382 100
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT